Bioventix Plc logo

Bioventix Plc (51B)

Market Open
11 Aug, 20:00
XDUS XDUS
16. 60
0
0%
- Market Cap
- P/E Ratio
1.62% Div Yield
0 Volume
- Eps
16.6
Previous Close
Add Transaction
Day Range
16.6 17.1
Year Range
16 28.6
Want to track 51B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

51B trading today higher at €16.6, an increase of 0% from yesterday's close, completing a monthly decrease of -8.7912% or -€1.6. Over the past 12 months, 51B stock lost -20.1923%.
51B is not paying dividends to its shareholders.
The last earnings report, released on Mar 30, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

51B Chart

Bioventix Plc (51B) FAQ

What is the stock price today?

The current price is €16.60.

On which exchange is it traded?

Bioventix Plc is listed on XDUS.

What is its stock symbol?

The ticker symbol is 51B.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.62%.

What is its market cap?

As of today, no market cap data is available.

Has Bioventix Plc ever had a stock split?

No, there has never been a stock split.

Bioventix Plc Profile

Biotechnology Industry
Healthcare Sector
Mr. Peter John Harrison MA CEO
XDUS Exchange
GB00B4QVDF07 ISIN
United Kingdom Country
17 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Bioventix PLC is a biotechnology company specialized in the creation, manufacture, and supply of sheep monoclonal antibodies (SMAs) for use in diagnostic applications across the globe. Its portfolio serves a variety of medical and industrial testing needs, including thyroid function, vitamin D levels, cardiac markers, and more. Established in 2003, Bioventix is based in Farnham, the United Kingdom, positioning itself as a critical partner in the diagnostic and healthcare industry by providing high-quality, precise antibodies crucial for the development of various diagnostic tests.

Products and Services

  • Purified SMAs

    These antibodies are used in the diagnosis and monitoring of thyroid disorders, vitamin D deficiency, cardiac issues, fertility problems, drugs of abuse, and various oncology indications. Bioventix’s portfolio of purified sheep monoclonal antibodies showcases the company's capacity for innovation and its role in enhancing diagnostic accuracy and patient care.

  • Pyrene (HOP-G) ELISA Kit

    This product is designed to monitor human exposure to industrial pollutants, representing Bioventix’s commitment to public health and safety. The kit uses enzyme-linked immunosorbent assay technology to detect hydroxypyrene, a metabolite of polycyclic aromatic hydrocarbons, which are major pollutants.

  • Contract SMAs and Recombinant Services

    Bioventix offers custom antibody production services, providing clients with tailored solutions for their diagnostic and research needs. This service underscores the company’s flexibility and expertise in creating high-quality, specific antibodies to meet the diverse requirements of the diagnostic and biotechnology sectors.

Contact Information

Address: 7 Romans Business Park
Phone: 44 12 5272 8001